Archived VFC Program Letters
2025
- Flumist Replacement Program for CDC (PDF) December 29
- Clinical Letter for PENMENVY (MenABCWY) (PDF) October 31
- Clinical Letter for Clesrovimab (Enflonsia) Now Available from VFC (PDF) October 17
- Clinical Letter for VFC 2025-2026 COVID-19 Vaccine (PDF) October 14
2024
- Vaccinating American Indian and Alaska Native (AI/AN) Children (PDF) November 25
- Clinical Letter for JYNNEOS™ Mpox Vaccine through VFC (PDF) November 8
- Clinical Letter for Penbraya (MenABCWY vaccine) (PDF) May 16
- Clinical Letter for RSVpreF Vaccine (Abrysvo™) (PDF) January 19
2023
- Clinical Letter for Nirsevimab (Beyfortus) (PDF) October 11
- Clinical Letter for Prevnar (PCV20) (PDF) September 1
- Clinical Letter for Menveo® One-Vial (PDF) September 1
- Unannounced Storage and Handling Visits (PDF) August 24
2022
- Clinical Letter for Vaxneuvance (PCV15) (PDF) November 30
- Clinical Letter for Priorix (MMR) (PDF) November 30
2021
- Clinical Letter for MenQuadfiTM (MenACWY Vaccine) through VFC (PDF) July 8
- Clinical Letter for VaxelisTM (DTaP-IPV-Hib-HepB Vaccine) through VFC (PDF) July 8
2019
- Immunization Quality Improvement for Providers (IQIP) Program (PDF) November 19
- Vaccine Management During Power Shut-off (PDF) September 26
2017
- Clinical Letter for Quadracel (PDF) May 30
- Clinical Letter for HPV 2 Dose Schedule February 15
2015
2012
- Clinical Letter for MMRV (PDF) November 19